Evidence map›Paper›PMID 29989171›Full record

Trial reportThe Journal of physiology2018

Redox-regulation of haemostasis in hypoxic exercising humans: a randomised double-blind placebo-controlled antioxidant study.

Lewis Fall, Julien V Brugniaux, Danielle Davis, Christopher J Marley, Bruce Davies, Karl J New, Jane McEneny, Ian S Young, Damian M Bailey

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of physiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Lewis FallNeurovascular Research Laboratory, University of South Wales, Pontypridd, UK.
Julien V BrugniauxSchool of Health, Western Sydney University, Sydney, Australia.
Danielle DavisDepartment of Sport Health and Nutrition, Leeds Trinity University, Leeds, UK.
Christopher J MarleyNeurovascular Research Laboratory, University of South Wales, Pontypridd, UK.
Bruce DaviesNeurovascular Research Laboratory, University of South Wales, Pontypridd, UK.
Karl J NewNeurovascular Research Laboratory, University of South Wales, Pontypridd, UK.
Jane McEnenyCentre for Public Health, Queen's University Belfast, Belfast, UK.
Ian S YoungCentre for Public Health, Queen's University Belfast, Belfast, UK.
Damian M BaileyNeurovascular Research Laboratory, University of South Wales, Pontypridd, UK.ORCID 0000-0003-0498-7095
University of South Wales · GBQueen's University Belfast · GBLeeds Trinity University · GBWestern Sydney University · AU

Funding

Higher Education Funding Council for Wales N/ARoyal Society Wolfson Research Fellowship WM170007
6 · The paper itself

Abstract

key pointsIn vitro evidence has identified that coagulation is activated by increased oxidative stress, though the link and underlying mechanism in humans have yet to be established. We conducted the first randomised controlled trial in healthy participants to examine if oral antioxidant prophylaxis alters the haemostatic responses to hypoxia and exercise given their synergistic capacity to promote free radical formation. Systemic free radical formation was shown to increase during hypoxia and was further compounded by exercise, responses that were attenuated by antioxidant prophylaxis. In contrast, antioxidant prophylaxis increased thrombin generation at rest in normoxia, and this was normalised only in the face of prevailing oxidation. Collectively, these findings suggest that human free radical formation is an adaptive phenomenon that serves to maintain vascular haemostasis. ABSTRACT: In vitro evidence suggests that blood coagulation is activated by increased oxidative stress although the link and underlying mechanism in humans have yet to be established. We conducted the first randomised controlled trial to examine if oral antioxidant prophylaxis alters the haemostatic responses to hypoxia and exercise. Healthy males were randomly assigned double-blind to either an antioxidant (n = 20) or placebo group (n = 16). The antioxidant group ingested two capsules/day that each contained 500 mg of l-ascorbic acid and 450 international units (IU) of dl-α-tocopherol acetate for 8 weeks. The placebo group ingested capsules of identical external appearance, taste and smell (cellulose). Both groups were subsequently exposed to acute hypoxia and maximal physical exercise with venous blood sampled pre-supplementation (normoxia), post-supplementation at rest (normoxia and hypoxia) and following maximal exercise (hypoxia). Systemic free radical formation (electron paramagnetic resonance spectroscopic detection of the ascorbate radical (A

Indexed as

ExerciseHemostasisAdultAltitude SicknessAntioxidantsAscorbic AcidCarotenoidsHumansMaleThrombinTocopherolsZeaxanthinsAntioxidantsAscorbic AcidCarotenoidsThrombinTocopherolsZeaxanthinsactivated coagulationexercisehaemostasishypoxiaoxidative stress

Identifiers

PMID29989171
PMCPMC6187039
OpenAlexW2892130245

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.